AIDS Weekly

Conference Coverage (ICAAC) - Fauci: Modulation of Cell Factors Could Halt Spread of HIV

Conference Coverage (ICAAC) - Immunization Could Prevent Deafness

Conference Coverage (ICAAC) - Monotherapy Called "Substandard Practice"

Conference Coverage (ICAAC) - Rifampin Resistance Rises Among HIV Infected in NYC

AIDS Therapies - AIDS Treatment on Verge of Cytokine Era

AIDS Therapies - Protease Inhibitors: Drug Interactions Reported

AIDS Therapies (Clinical Trials) - Trial Results for AIDS Oral Dose VIMRxyn Presented

AIDS Therapies (IL-2) - Drug Boosts Immune System In AIDS Cases

AIDS Therapies (Protease Inhibitors) - Combining Two Similar Drugs Reduces HIV Level in Blood

AIDS Therapies (Remune) - Publication of Clinical Trial Data Announced

At-Risk Populations - TB Most Common Cause of Meningitis in IVDUs

Candidiasis (Drug Resistance) - Resistant Fungal Infections Pose Problems for AIDS Management

Chronic Diarrhea - Berberine May Ease AIDS Related Diarrhea

Cytomegalovirus Retinitis - Resistance to Ganciclovir Increasingly Recognized

Disease Associations - Atovaquone Suppresses AIDS Related Toxoplasmic Encephalitis

Disease Associations - Diarrhea Compromises Quality of Life in HIV Patients

HIV (Testing) - Home Access HIV-1 System Available at Eckerd Drugstores

HIV Vaccines - A Live Inactivatable Attenuated Vaccine for HIV Has Been Proposed

International (Africa) - Approval and Launch of Marinol in South Africa Announced

International (Asia) - Blood Safety: Improvements Needed In Thailand

International (Europe) - Romanian Government Blasted for Neglecting AIDS Children

International (South America) - HIV-1 Infection May Be on the Rise in Peru

Non-Hodgkin's Lymphoma - Lung Involvement Common in AIDS Related Lymphoma

Occupational Risk - Funeral Directors and Farmers At Risk for Tuberculosis

Prisons - Sex and Drugs Behind Bars Carry HIV Risk

Prophylaxis - Global Public Sector Purchase of Female Condom Supported

Therapy (HCV) - IFN-(alpha) is Useful in HIV Infected Patients with CD4⁺ >200

Therapy (TB) - DOT Can Work in Rural, Underdeveloped Regions